Key statistics
As of last trade, Actinogen Medical Ltd (ACW:ASX) traded at 0.0415, 118.42% above the 52 week low of 0.019 set on Jun 24, 2025.
52-week range
| Open | 0.041 |
|---|---|
| High | 0.042 |
| Low | 0.04 |
| Bid | 0.041 |
| Offer | 0.042 |
| Previous close | 0.04 |
| Average volume | 3.04m |
|---|---|
| Shares outstanding | 3.58bn |
| Free float | 3.29bn |
| P/E (TTM) | -- |
| Market cap | 143.02m AUD |
| EPS (TTM) | -0.0058 AUD |
Data delayed at least 20 minutes, as of Mar 05 2026 00:57 GMT.
More ▼
- Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
- Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
- Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
- Actinogen provides pivotal Alzheimer’s trial enrolment update and other business news
